Replies to post #87971 on Biotech Values

[mcbio]

Re: ARRY partnering

Has ARRY indicated that they plan to go it alone on any of their products or are they trying to partner everything?

They indicated in a prior call that they could potentially attempt to bring ARRY-520 (for MM and/or AML) to market on their own. But this was only after speculating on when a potential partner might be interested in the compound (after PoC data in mid-2010) and I really didn't get the impression they were seriously considering this option. I expect they will try to partner pretty much every drug that is garnering interest as they are small and don't really have the resources right now to try to go it alone on anything, especially given the large number of drugs they are working on.